1.1.1.112	1,10-phenanthroline	competitive inhibition vs. indanol	62	
1.1.1.112	1,10-phenanthroline	1 mM, 19% inhibition	62	
1.1.1.112	2,2'-bipyridine	competitive inhibition vs. indanol	2457	
1.1.1.112	2,2'-bipyridine	1 mM, 30% inhibition	2457	
1.1.1.112	4,4'-Bipyridine	competitive inhibition vs. indanol	43387	
1.1.1.112	6alpha-Methylprednisolone	0.1 mM, oxidation of acenaphthenol: 0% inhibition of isozyme 1, 40% inhibition of isozyme 2, 23%,inhibition of isozyme 3, 89% inhibition of isozyme 4, 14% inhibition of isozyme 5, 22% inhibition of isozyme 6 and 18% inhibition of isoenzyme 7, oxidation of 5alpha-androstane-3alpha,17beta-diol: 7% inhibition of isozyme 1, 41% inhibition of isozyme 2, 30%,inhibition of isozyme 3, 86% inhibition of isozyme 4, 11% inhibition of isozyme 5, 16% inhibition of isozyme 6 and 20% inhibition of isoenzyme 7	20074	
1.1.1.112	8-hydroxyquinoline	competitive inhibition vs. indanol	321	
1.1.1.112	8-hydroxyquinoline	1 mM, 84% inhibition, 0.1 mM, 40% inhibition	321	
1.1.1.112	betamethazone	0.05 mM, oxidation of acenaphthenol: 32% inhibition of isozyme 1, 16% inhibition of isozyme 2, 90%,inhibition of isozyme 3, 95% inhibition of isozyme 4, 27% inhibition of isozyme 5, 22% inhibition of isozyme 6 and 0% inhibition of isoenzyme 7, oxidation of 5alpha-androstane-3alpha,17beta-diol: 14% inhibition of isozyme 1, 26% inhibition of isozyme 2, 97%,inhibition of isozyme 3, 96% inhibition of isozyme 4, 30% inhibition of isozyme 5, 22% inhibition of isozyme 6 and 6% inhibition of isoenzyme 7	105589	
1.1.1.112	Cibacron blue	noncompetitive inhibition vs. indanol	1138